The hallmarks of cancer immune evasion

C Galassi, TA Chan, I Vitale, L Galluzzi - Cancer Cell, 2024 - cell.com
According to the widely accepted" three Es" model, the host immune system eliminates
malignant cell precursors and contains microscopic neoplasms in a dynamic equilibrium …

The balance of STING signaling orchestrates immunity in cancer

KRB Lanng, EL Lauridsen, MR Jakobsen - Nature Immunology, 2024 - nature.com
Over the past decade, it has become clear that the stimulator of interferon genes (STING)
pathway is critical for a variety of immune responses. This endoplasmic reticulum-anchored …

[HTML][HTML] Mechanisms and regulation of replication fork reversal

MB Adolph, D Cortez - DNA repair, 2024 - Elsevier
DNA replication is remarkably accurate with estimates of only a handful of mutations per
human genome per cell division cycle. Replication stress caused by DNA lesions …

HLTF resolves G4s and promotes G4-induced replication fork slowing to maintain genome stability

G Bai, T Endres, U Kühbacher, V Mengoli, BH Greer… - Molecular cell, 2024 - cell.com
Summary G-quadruplexes (G4s) form throughout the genome and influence important
cellular processes. Their deregulation can challenge DNA replication fork progression and …

Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8+ T cell exhaustion

B Wang, W Liu, M Zhang, Y Li, H Tang, Y Wang… - Journal of …, 2024 - Springer
Background While small extracellular vesicles (sEVs)-derived circular RNAs (circRNAs)
have been emerged as significant players in cancer, the function and underlying mechanism …

Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer

BB Sun, GZ Wang, SC Han, FY Yang, H Guo, J Liu… - Cancer Letters, 2024 - Elsevier
Small cell lung cancer (SCLC) is a recalcitrant cancer characterized by high frequency loss-
of-function mutations in tumor suppressors with a lack of targeted therapy due to absence of …

Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1

Z Yang, X Liu, J Zhu, Y Chai, B Cong, B Li, W Gao… - Cancer Cell, 2025 - cell.com
Deciphering mechanisms for cancer immune escape may provide targets for improving
immunotherapy efficacy. By in vivo genome-wide CRISPR loss-of-function screening in a …

[HTML][HTML] Exosomes: key factors in ovarian cancer peritoneal metastasis and drug resistance

M Shao, Y Gao, X Xu, DW Chan, J Du - Biomolecules, 2024 - mdpi.com
Ovarian cancer remains a leading cause of death among gynecological cancers, largely due
to its propensity for peritoneal metastasis and the development of drug resistance. This …

cGAS/STING in skin melanoma: from molecular mechanisms to therapeutics

J Mahin, X Xu, L Li, C Zhang - Cell Communication and Signaling, 2024 - Springer
Melanoma, recognized as the most aggressive type of skin cancer, has experienced a
notable increase in cases, especially within populations with fair skin. This highly aggressive …

[HTML][HTML] Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis

K Guo, J Yang, R Jiang, X Ren, P Liu, W Wang… - Pharmaceuticals, 2024 - mdpi.com
Background: Gliomas, the most prevalent type of primary brain tumor, stand out as one of the
most aggressive and lethal types of human cancer. Methods & Results: To uncover potential …